ConductScience.org, home

Library / Genes

STAT2: signal transducer and activator of transcription 2

1 protein, 80 patents, 0 drugs, 0 trials, 4,747 NIH grants and 7,456 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolSTAT2HGNC
Namesignal transducer and activator of transcription 2HGNC
NCBI Gene ID6773NCBI Gene
HGNC IDHGNC:11363HGNC
EnsemblENSG00000170581NCBI Gene
AliasesIMD44, ISGF-3, P113, PTORCH3, STAT113NCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
P52630Signal transducer and activator of transcription 28516Ensembl, GeneID, HGNCUniProt

Patents 80

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
EP 4650780 A22025-11-195035P52630Espacenet
EP 4640849 A22025-10-29703P52630Espacenet
EP 4641201 A22025-10-294617P52630Espacenet
JP 2025147176 A2025-10-0615695P52630Espacenet
JP 2025519096 A2025-06-24703P52630Espacenet
JP 2025517969 A2025-06-124617P52630Espacenet
JP 2025517970 A2025-06-125035P52630Espacenet
JP 2025032204 A2025-03-1136657P52630Espacenet
JP 2025028160 A2025-02-2815695P52630Espacenet
KR 1020250010750 A2025-01-2115695P52630Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 4747

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
UL1TR001866Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success372,025NIH's project files
P30CA008748Cancer Center Support Grant232,025NIH's project files
P30CA016672Cancer Center Support Grant202,025NIH's project files
U19AI057266Vaccine and Infection Induced Immunity in the Young and Aged192,025NIH's project files
UL1TR001863Yale Clinical and Translational Science Award162,025NIH's project files
R01AI163029Inborn errors of immunity in patients with life-threatening COVID-19152,025NIH's project files
P30CA016058Cancer Center Support Grant142,025NIH's project files
R01AR050401Cytokine Balance in Rheumatoid Arthritis132,025NIH's project files
U19AI082630Durable Alteration of the Human Immune system after Infection or Immunotherapy122,025NIH's project files
U19AI135972SARS-CoV adaptations through a Systems Biology Lens (SYBIL)122,025NIH's project files

Papers 7456

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42801537PubTator, text miningPubMed
42794461PubTator, text miningPubMed
42792593PubTator, text miningPubMed
42753295PubTator, text miningPubMed
42722097PubTator, text miningPubMed
42700277PubTator, text miningPubMed
42699205PubTator, text miningPubMed
42674818PubTator, text miningPubMed
42674453PubTator, text miningPubMed
42674244PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license